Donepezil Registration approved

ABEX Pharmaceutica received approval for two separate marketing Authorisations for the molecule donepezil in July. These submissions were processed on behalf of Specifar (Greece), part of the Watson Pharma group and will be made available to selected partners for license and supply arrangements. 
The brand DONERIN will be marketed by Watson Pharma in South Africa.